http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 06 Jan 2026 11:58:27 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Investing/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html <img src="https://i-invdn-com.investing.com/news/LYNXNPEAAH0DL_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="2">Investing.com -- The monthslong tug-of-war for the future of STAAR Surgical Company (NASDAQ:STAA) ended Tuesday with a white flag. After four shareholder meeting postponements and a bitter proxy battle, the implantable lensmaker announced its intention to terminate its merger agreement with Swiss eye care giant Alcon AG (NYSE:ALC) after failing to secure enough shareholder support.</p> <p data-path-to-node="3">The collapse comes despite aggressive last-minute efforts by <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Alcon</span></span> and STAAR leadership to entice a skeptical investor base. Over the last quarter, the companies increased the bid to $30.75 per share, initiated a "go-shop" http://www.streetinsider.com/Investing/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html Tue, 06 Jan 2026 11:58:27 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html <img src="https://i-invdn-com.investing.com/news/LYNXNPEAAH0DL_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="2">Investing.com -- The monthslong tug-of-war for the future of STAAR Surgical Company (NASDAQ:STAA) ended Tuesday with a white flag. After four shareholder meeting postponements and a bitter proxy battle, the implantable lensmaker announced its intention to terminate its merger agreement with Swiss eye care giant Alcon AG (NYSE:ALC) after failing to secure enough shareholder support.</p> <p data-path-to-node="3">The collapse comes despite aggressive last-minute efforts by <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Alcon</span></span> and STAAR leadership to entice a skeptical investor base. Over the last quarter, the companies increased the bid to $30.75 per share, initiated a "go-shop" http://www.streetinsider.com/Investing/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html Tue, 06 Jan 2026 11:58:27 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html <img src="https://i-invdn-com.investing.com/news/LYNXNPEAAH0DL_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="2">Investing.com -- The monthslong tug-of-war for the future of STAAR Surgical Company (NASDAQ:STAA) ended Tuesday with a white flag. After four shareholder meeting postponements and a bitter proxy battle, the implantable lensmaker announced its intention to terminate its merger agreement with Swiss eye care giant Alcon AG (NYSE:ALC) after failing to secure enough shareholder support.</p> <p data-path-to-node="3">The collapse comes despite aggressive last-minute efforts by <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Alcon</span></span> and STAAR leadership to entice a skeptical investor base. Over the last quarter, the companies increased the bid to $30.75 per share, initiated a "go-shop" http://www.streetinsider.com/Investing/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html Tue, 06 Jan 2026 11:58:27 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html <img src="https://i-invdn-com.investing.com/news/LYNXNPEAAH0DL_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="2">Investing.com -- The monthslong tug-of-war for the future of STAAR Surgical Company (NASDAQ:STAA) ended Tuesday with a white flag. After four shareholder meeting postponements and a bitter proxy battle, the implantable lensmaker announced its intention to terminate its merger agreement with Swiss eye care giant Alcon AG (NYSE:ALC) after failing to secure enough shareholder support.</p> <p data-path-to-node="3">The collapse comes despite aggressive last-minute efforts by <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Alcon</span></span> and STAAR leadership to entice a skeptical investor base. Over the last quarter, the companies increased the bid to $30.75 per share, initiated a "go-shop" http://www.streetinsider.com/General+News/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html Tue, 06 Jan 2026 11:58:27 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html <img src="https://i-invdn-com.investing.com/news/LYNXNPEAAH0DL_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="2">Investing.com -- The monthslong tug-of-war for the future of STAAR Surgical Company (NASDAQ:STAA) ended Tuesday with a white flag. After four shareholder meeting postponements and a bitter proxy battle, the implantable lensmaker announced its intention to terminate its merger agreement with Swiss eye care giant Alcon AG (NYSE:ALC) after failing to secure enough shareholder support.</p> <p data-path-to-node="3">The collapse comes despite aggressive last-minute efforts by <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Alcon</span></span> and STAAR leadership to entice a skeptical investor base. Over the last quarter, the companies increased the bid to $30.75 per share, initiated a "go-shop" http://www.streetinsider.com/General+News/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html Tue, 06 Jan 2026 11:58:27 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html <img src="https://i-invdn-com.investing.com/news/LYNXNPEAAH0DL_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="2">Investing.com -- The monthslong tug-of-war for the future of STAAR Surgical Company (NASDAQ:STAA) ended Tuesday with a white flag. After four shareholder meeting postponements and a bitter proxy battle, the implantable lensmaker announced its intention to terminate its merger agreement with Swiss eye care giant Alcon AG (NYSE:ALC) after failing to secure enough shareholder support.</p> <p data-path-to-node="3">The collapse comes despite aggressive last-minute efforts by <span itemscope="" itemtype="http://schema.org/Corporation"><span itemprop="name">Alcon</span></span> and STAAR leadership to entice a skeptical investor base. Over the last quarter, the companies increased the bid to $30.75 per share, initiated a "go-shop" http://www.streetinsider.com/General+News/Exclusive%3A+STAAR+Surgical+deal+fails+as+shareholder+support+remains+at+around+30%25/25811647.html Tue, 06 Jan 2026 11:58:27 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html <p dir="ltr">Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a deeply fractured shareholder vote on December 19. The market’s uncertainty peaked Tuesday after leading independent proxy advisory firm Institutional Shareholder Services (ISS) issued its recommendation, casting doubt on whether the controversial merger will pass with shareholders.</p><p>While the STAAR board announced late Monday that ISS had recommended a "FOR" vote on the raised $30.75 per share deal, activist shareholder Broadwood Partners immediately seized on the fine print, noting ISS also http://www.streetinsider.com/General+News/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html Tue, 16 Dec 2025 16:06:37 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html <p dir="ltr">Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a deeply fractured shareholder vote on December 19. The market’s uncertainty peaked Tuesday after leading independent proxy advisory firm Institutional Shareholder Services (ISS) issued its recommendation, casting doubt on whether the controversial merger will pass with shareholders.</p><p>While the STAAR board announced late Monday that ISS had recommended a "FOR" vote on the raised $30.75 per share deal, activist shareholder Broadwood Partners immediately seized on the fine print, noting ISS also http://www.streetinsider.com/General+News/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html Tue, 16 Dec 2025 16:06:37 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html <p dir="ltr">Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a deeply fractured shareholder vote on December 19. The market’s uncertainty peaked Tuesday after leading independent proxy advisory firm Institutional Shareholder Services (ISS) issued its recommendation, casting doubt on whether the controversial merger will pass with shareholders.</p><p>While the STAAR board announced late Monday that ISS had recommended a "FOR" vote on the raised $30.75 per share deal, activist shareholder Broadwood Partners immediately seized on the fine print, noting ISS also http://www.streetinsider.com/General+News/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html Tue, 16 Dec 2025 16:06:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html <p dir="ltr">Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a deeply fractured shareholder vote on December 19. The market’s uncertainty peaked Tuesday after leading independent proxy advisory firm Institutional Shareholder Services (ISS) issued its recommendation, casting doubt on whether the controversial merger will pass with shareholders.</p><p>While the STAAR board announced late Monday that ISS had recommended a "FOR" vote on the raised $30.75 per share deal, activist shareholder Broadwood Partners immediately seized on the fine print, noting ISS also http://www.streetinsider.com/Investing/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html Tue, 16 Dec 2025 16:06:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html <p dir="ltr">Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a deeply fractured shareholder vote on December 19. The market’s uncertainty peaked Tuesday after leading independent proxy advisory firm Institutional Shareholder Services (ISS) issued its recommendation, casting doubt on whether the controversial merger will pass with shareholders.</p><p>While the STAAR board announced late Monday that ISS had recommended a "FOR" vote on the raised $30.75 per share deal, activist shareholder Broadwood Partners immediately seized on the fine print, noting ISS also http://www.streetinsider.com/Investing/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html Tue, 16 Dec 2025 16:06:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html <p dir="ltr">Investing.com -- The protracted, $1.6 billion dollar saga over STAAR Surgical Company (NASDAQ:STAA) is entering its final, chaotic phase with the acquisition by Alcon AG (NYSE:ALC) now hinged on a deeply fractured shareholder vote on December 19. The market’s uncertainty peaked Tuesday after leading independent proxy advisory firm Institutional Shareholder Services (ISS) issued its recommendation, casting doubt on whether the controversial merger will pass with shareholders.</p><p>While the STAAR board announced late Monday that ISS had recommended a "FOR" vote on the raised $30.75 per share deal, activist shareholder Broadwood Partners immediately seized on the fine print, noting ISS also http://www.streetinsider.com/Investing/ISS+recommends+STAAR+Surgical+deal%2C+but+warns+shareholders+have+reason+to+object/25746986.html Tue, 16 Dec 2025 16:06:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html <img src="https://i-invdn-com.investing.com/news/LYNXMPED351E0_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="1">Investing.com -- <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> STAAR Surgical </span></span> Company (NASDAQ:STAA) shares ticked down 5.5% on Wednesday, reversing some of the previous day’s gains, as another major institutional investor, Yunqi Capital, reaffirmed its opposition to the revised, higher takeover offer from Alcon AG (NYSE:ALC).</p> <p data-path-to-node="2">The $1.6 billion all-cash deal, which was sweetened to $30.75 per share from $28 to quell a fierce shareholder revolt, now faces a multi-front opposition just nine days before the decisive shareholder vote on December 19.</p> <p data-path-to-node="3">Hong Kong-based Yunqi Capital, which holds a 5.1% stake in http://www.streetinsider.com/Investing/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html Wed, 10 Dec 2025 13:56:28 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html <img src="https://i-invdn-com.investing.com/news/LYNXMPED351E0_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="1">Investing.com -- <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> STAAR Surgical </span></span> Company (NASDAQ:STAA) shares ticked down 5.5% on Wednesday, reversing some of the previous day’s gains, as another major institutional investor, Yunqi Capital, reaffirmed its opposition to the revised, higher takeover offer from Alcon AG (NYSE:ALC).</p> <p data-path-to-node="2">The $1.6 billion all-cash deal, which was sweetened to $30.75 per share from $28 to quell a fierce shareholder revolt, now faces a multi-front opposition just nine days before the decisive shareholder vote on December 19.</p> <p data-path-to-node="3">Hong Kong-based Yunqi Capital, which holds a 5.1% stake in http://www.streetinsider.com/Investing/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html Wed, 10 Dec 2025 13:56:28 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html <img src="https://i-invdn-com.investing.com/news/LYNXMPED351E0_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="1">Investing.com -- <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> STAAR Surgical </span></span> Company (NASDAQ:STAA) shares ticked down 5.5% on Wednesday, reversing some of the previous day’s gains, as another major institutional investor, Yunqi Capital, reaffirmed its opposition to the revised, higher takeover offer from Alcon AG (NYSE:ALC).</p> <p data-path-to-node="2">The $1.6 billion all-cash deal, which was sweetened to $30.75 per share from $28 to quell a fierce shareholder revolt, now faces a multi-front opposition just nine days before the decisive shareholder vote on December 19.</p> <p data-path-to-node="3">Hong Kong-based Yunqi Capital, which holds a 5.1% stake in http://www.streetinsider.com/Investing/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html Wed, 10 Dec 2025 13:56:28 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html <img src="https://i-invdn-com.investing.com/news/LYNXMPED351E0_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="1">Investing.com -- <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> STAAR Surgical </span></span> Company (NASDAQ:STAA) shares ticked down 5.5% on Wednesday, reversing some of the previous day’s gains, as another major institutional investor, Yunqi Capital, reaffirmed its opposition to the revised, higher takeover offer from Alcon AG (NYSE:ALC).</p> <p data-path-to-node="2">The $1.6 billion all-cash deal, which was sweetened to $30.75 per share from $28 to quell a fierce shareholder revolt, now faces a multi-front opposition just nine days before the decisive shareholder vote on December 19.</p> <p data-path-to-node="3">Hong Kong-based Yunqi Capital, which holds a 5.1% stake in http://www.streetinsider.com/General+News/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html Wed, 10 Dec 2025 13:56:28 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html <img src="https://i-invdn-com.investing.com/news/LYNXMPED351E0_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="1">Investing.com -- <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> STAAR Surgical </span></span> Company (NASDAQ:STAA) shares ticked down 5.5% on Wednesday, reversing some of the previous day’s gains, as another major institutional investor, Yunqi Capital, reaffirmed its opposition to the revised, higher takeover offer from Alcon AG (NYSE:ALC).</p> <p data-path-to-node="2">The $1.6 billion all-cash deal, which was sweetened to $30.75 per share from $28 to quell a fierce shareholder revolt, now faces a multi-front opposition just nine days before the decisive shareholder vote on December 19.</p> <p data-path-to-node="3">Hong Kong-based Yunqi Capital, which holds a 5.1% stake in http://www.streetinsider.com/General+News/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html Wed, 10 Dec 2025 13:56:28 -0500 ALC ALCC STAA http://www.streetinsider.com/General+News/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html <img src="https://i-invdn-com.investing.com/news/LYNXMPED351E0_M.jpg" width="650" height="410" align="right" alt="" title=" " /><p data-path-to-node="1">Investing.com -- <span itemscope itemtype="http://schema.org/Corporation"><span itemprop="name"> STAAR Surgical </span></span> Company (NASDAQ:STAA) shares ticked down 5.5% on Wednesday, reversing some of the previous day’s gains, as another major institutional investor, Yunqi Capital, reaffirmed its opposition to the revised, higher takeover offer from Alcon AG (NYSE:ALC).</p> <p data-path-to-node="2">The $1.6 billion all-cash deal, which was sweetened to $30.75 per share from $28 to quell a fierce shareholder revolt, now faces a multi-front opposition just nine days before the decisive shareholder vote on December 19.</p> <p data-path-to-node="3">Hong Kong-based Yunqi Capital, which holds a 5.1% stake in http://www.streetinsider.com/General+News/STAAR+Surgical+falls+as+Yunqi+Capital+reiterates+opposition+to+merger+with+Alcon/25723291.html Wed, 10 Dec 2025 13:56:28 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html (Updated - December 9, 2025 2:00 PM EST) <p>Investing.com -- The high-stakes acquisition of STAAR Surgical Company (NASDAQ: STAA) reached a critical juncture today as Alcon AG (NYSE: ALC) announced an amended merger agreement, raising its all-cash offer to $30.75 per share, up from the original $28. The approximately $1.6 billion deal, an attempt to secure shareholder support ahead of the December 19 vote, immediately sent STAAR shares soaring over 15% in morning trading. That number ticked down by 5% once activist shareholder Broadwood Partners reiterated its opposition despite the raised bid.</p><p>The price increase, which also includes a reported reduction in http://www.streetinsider.com/Investing/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html Tue, 09 Dec 2025 14:00:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html (Updated - December 9, 2025 2:00 PM EST) <p>Investing.com -- The high-stakes acquisition of STAAR Surgical Company (NASDAQ: STAA) reached a critical juncture today as Alcon AG (NYSE: ALC) announced an amended merger agreement, raising its all-cash offer to $30.75 per share, up from the original $28. The approximately $1.6 billion deal, an attempt to secure shareholder support ahead of the December 19 vote, immediately sent STAAR shares soaring over 15% in morning trading. That number ticked down by 5% once activist shareholder Broadwood Partners reiterated its opposition despite the raised bid.</p><p>The price increase, which also includes a reported reduction in http://www.streetinsider.com/Investing/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html Tue, 09 Dec 2025 14:00:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html (Updated - December 9, 2025 2:00 PM EST) <p>Investing.com -- The high-stakes acquisition of STAAR Surgical Company (NASDAQ: STAA) reached a critical juncture today as Alcon AG (NYSE: ALC) announced an amended merger agreement, raising its all-cash offer to $30.75 per share, up from the original $28. The approximately $1.6 billion deal, an attempt to secure shareholder support ahead of the December 19 vote, immediately sent STAAR shares soaring over 15% in morning trading. That number ticked down by 5% once activist shareholder Broadwood Partners reiterated its opposition despite the raised bid.</p><p>The price increase, which also includes a reported reduction in http://www.streetinsider.com/Investing/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html Tue, 09 Dec 2025 14:00:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Mergers+and+Acquisitions/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html (Updated - December 9, 2025 2:00 PM EST) <p>Investing.com -- The high-stakes acquisition of STAAR Surgical Company (NASDAQ: STAA) reached a critical juncture today as Alcon AG (NYSE: ALC) announced an amended merger agreement, raising its all-cash offer to $30.75 per share, up from the original $28. The approximately $1.6 billion deal, an attempt to secure shareholder support ahead of the December 19 vote, immediately sent STAAR shares soaring over 15% in morning trading. That number ticked down by 5% once activist shareholder Broadwood Partners reiterated its opposition despite the raised bid.</p><p>The price increase, which also includes a reported reduction in http://www.streetinsider.com/Mergers+and+Acquisitions/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html Tue, 09 Dec 2025 14:00:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Mergers+and+Acquisitions/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html (Updated - December 9, 2025 2:00 PM EST) <p>Investing.com -- The high-stakes acquisition of STAAR Surgical Company (NASDAQ: STAA) reached a critical juncture today as Alcon AG (NYSE: ALC) announced an amended merger agreement, raising its all-cash offer to $30.75 per share, up from the original $28. The approximately $1.6 billion deal, an attempt to secure shareholder support ahead of the December 19 vote, immediately sent STAAR shares soaring over 15% in morning trading. That number ticked down by 5% once activist shareholder Broadwood Partners reiterated its opposition despite the raised bid.</p><p>The price increase, which also includes a reported reduction in http://www.streetinsider.com/Mergers+and+Acquisitions/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html Tue, 09 Dec 2025 14:00:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Mergers+and+Acquisitions/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html (Updated - December 9, 2025 2:00 PM EST) <p>Investing.com -- The high-stakes acquisition of STAAR Surgical Company (NASDAQ: STAA) reached a critical juncture today as Alcon AG (NYSE: ALC) announced an amended merger agreement, raising its all-cash offer to $30.75 per share, up from the original $28. The approximately $1.6 billion deal, an attempt to secure shareholder support ahead of the December 19 vote, immediately sent STAAR shares soaring over 15% in morning trading. That number ticked down by 5% once activist shareholder Broadwood Partners reiterated its opposition despite the raised bid.</p><p>The price increase, which also includes a reported reduction in http://www.streetinsider.com/Mergers+and+Acquisitions/Alcon+bumps+STAAR+Surgical+bid+to+%2430.75%2C+but+Broadwood+remains+vehemently+against/25717536.html Tue, 09 Dec 2025 14:00:37 -0500 ALC ALCC STAA http://www.streetinsider.com/Investing/STAAR+Surgical+reveals+board+dissent+over+amended+Alcon+deal+ahead+of+vote/25631623.html <p>Investing.com -- STAAR Surgical Company (NASDAQ: STAA) disclosed new details about board deliberations surrounding its amended $28-per-share sale to Alcon AG (NYSE: ALC), revealing on Monday that the board is no longer unanimous in its support for the revised terms and that CEO Stephen Farrell was unable to secure a price increase before directors voted to proceed.</p><p>In supplemental proxy materials filed ahead of the company’s December 19 shareholder vote, STAAR said that one director dissented during the board’s approval of amendments to the merger agreement. The dissenting director argued that certain shareholders had already voiced concerns about the deal and http://www.streetinsider.com/Investing/STAAR+Surgical+reveals+board+dissent+over+amended+Alcon+deal+ahead+of+vote/25631623.html Tue, 18 Nov 2025 15:53:28 -0500 ALC ALCC STAA